Drug Development Course
The big puzzle for start-up companies: How to bring your molecule successful to the clinic!
Therefore, DGr Pharma organizes a Drug Development Course from Lead Selection up to Clinical Phase I/IIa. The course will include all relevant CMC, non-clinical, clinical and regulatory aspects. Sign up!
Key Takeaways
- Why is it essential to have a Target Product Profile and a Drug Development Plan
- What would investors like to know about your development program?
- How to select CMOs/CROs?
Programme
Wed 28 May, 08.30-16.30
08:30-09:00 Registration and mingle with coffee.
09:00-09:15 Opening of course.
09:15-09:45 Drug development overview including global R&D trends.
09:45-10:45 Drug discovery, Target identification/validation, Lead optimization and candidate selection.
10:45-11:00 Coffee and tea break.
11:00-12:00 Pharmaceutical Development.
12:00-13:00 Lunch.
13:00-14:00 Biopharmaceuticals key differences with small molecules.
14:00-15:00 Non-Clinical Development and bridging to the clinic.
15:15-15:30 Coffee and tea break.
15:30-16:30 Early Clinical Development up to Proof-of-Concept.
16:30 Informal closure.
Meet the Experts
- Ron van ’t Hof, PhD, Director Chemistry, Manufacturing and Control.
- Marleen Janus, PhD, Senior Consultant Chemical-Pharmaceutical and Non-Clinical Development.
- Tanja van Viegen, PhD, MBA, PMP, Senior Clinical Trial Manager.
About DGr Pharma
DGr Pharma facilitates a fast and high-quality drug development process in close cooperation with the preclinical and clinical R&D departments of pharmaceutical and start-up companies through consultancy and contract research services.